Growth performance and immune response of two commercial broiler strains fed diets containing Lactobacillus cultures and oxytetracycline under heat stress conditions.
1. Hubbard x Hubbard (HH) and Shaver x Shaver (SS) chicks given a dietary supplement of either 50 mg/kg oxytetracycline (OTC) or 1 g/kg Lactobacillus culture (LC) were exposed to 36 +/- 1 degrees C for 3 h daily from day (d) 21 to 42. 2. Prior to heat treatment, body weight (d 21) and weight gain (d 1 to d 21) of OTC and LC birds were greater than those fed the control diet. Chicks given LC had the best food efficiency followed by OTC and control birds during d 1 to d 21. Body weight (d 1 and d 21) and weight gain (d 1 to d 21) were greater for HH tlhan SS chicks. 3. After 3 weeks of heat exposure, birds receiving the LC diet had greater body weight and weight gain, higher food intake and lower food efficiency than OTC and control chicks. 4. Antibody production against Newcastle discase vaccine on d 21 was not affected by strain or diet. On d 42, while diet had negligible effect on this variable among the SS broilers, HH birds fed LC had higher antibody production than those on the control diet. 5. Neither strain nor diet had a significant effect on mortality.
Zulkifli
I
I
Department of Animal Science, Universiti Putra, Malaysia, Selangor. zulkifli@agri.upm.edu.my
Abdulllah
N
N
Azrin
N M
NM
Ho
Y W
YW
D000821:Animal Feed; D000818:Animals; D000900:Anti-Bacterial Agents / Q000276:immunology / Q000494:pharmacology*; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000097:blood; D001835:Body Weight / Q000187:drug effects; D002645:Chickens / Q000254:growth & development* / Q000276:immunology* / Q000502:physiology; D019587:Dietary Supplements; D004435:Eating / Q000187:drug effects; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005260:Female; D018882:Heat Stress Disorders / Q000276:immunology* / Q000503:physiopathology / Q000517:prevention & control; D007778:Lactobacillus / Q000276:immunology*; D009522:Newcastle disease virus / Q000276:immunology; D010118:Oxytetracycline / Q000276:immunology / Q000494:pharmacology*; D019936:Probiotics / Q000494:pharmacology*; D014765:Viral Vaccines / Q000276:immunology
D000900:Anti-Bacterial Agents; D000914:Antibodies, Viral; D014765:Viral Vaccines; D010118:Oxytetracycline